Corrigendum to "Enrichment, sources, and distributions of toxic elements in the farming land's topsoil near a heavily industrialized area of central Bangladesh, and associated risks assessment" [Heliyon 9 (4) 2023 e15078].

[This corrects the article DOI: 10.1016/j.heliyon.

Enrichment, sources, and distributions of toxic elements in the farming land's topsoil near a heavily industrialized area of central Bangladesh, and associated risks assessment.

Toxic element accumulation in the surrounding soils of the advanced industry- and agriculture-oriented areas may lead to severe environmental degradation and harmful impact on inhabitants. This work examined the concentration of some concerned toxic elements (Cr, Pb, Cd, Cu, As, and Ni) in the representative topsoil from 10 industrially contaminated sites in central Bangladesh (Narayanganj district) using an Inductively Coupled Plasma Mass Spectrometer concerning the probable ecological and human health risks. The mean concentrations (mg/kg) of the elements were found in the order of Ni (58.

Obstructive sleep apnea, cerebrovascular disease, and amyloid in older adults with Down syndrome across the Alzheimer's continuum.

We determined the extent to which obstructive sleep apnea (OSA) is associated with increased cerebrovascular disease and amyloid burden, and the relation of the two processes across clinical Alzheimer's disease (AD) diagnostic groups in adults with Down syndrome (DS). Adults with DS from the Biomarkers of Alzheimer's Disease in Down Syndrome (ADDS) study were included given available research MRI ( = 116; 50 ± 8 years; 42% women) and amyloid PET scans ( = 71; 50 ± 7 years; 39% women) at the time of analysis. Participants were characterized as cognitively stable (CS; 64%), with mild cognitive impairment-DS (MCI-DS; 23%), with possible AD dementia (5%), or with definite AD dementia (8%).

Probing the proteome to explore potential correlates of increased Alzheimer's-related cerebrovascular disease in adults with Down syndrome.

Cerebrovascular disease is associated with symptoms and pathogenesis of Alzheimer's disease (AD) among adults with Down syndrome (DS). The cause of increased dementia-related cerebrovascular disease in DS is unknown. We explored whether protein markers of neuroinflammation are associated with markers of cerebrovascular disease among adults with DS.

Alzheimer-Related Cerebrovascular Disease in Down Syndrome.

Objective: Adults with Down syndrome (DS) develop Alzheimer disease (AD) pathology by their 5th decade. Compared with the general population, traditional vascular risks in adults with DS are rare, allowing examination of cerebrovascular disease in this population and insight into its role in AD without the confound of vascular risk factors. We examined in vivo magnetic resonance imaging (MRI)-based biomarkers of cerebrovascular pathology in adults with DS, and determined their cross-sectional relationship with age, beta-amyloid pathology, and mild cognitive impairment or clinical AD diagnostic status.